International Business News - NRGN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotechnology company Neurogen Corp. said Sunday it stopped a clinical trial of its insomnia candidate adipiplon because some patients experienced grogginess and memory loss. The stock plunged in Monday trading. http://www.ibtimes.com/articles/20080714/neurogen-stops-adipiplon-trial-due-to-side-effects.htm Mon, 14 Jul 2008 17:22:33 EDT